The fast-acting antigen test could save lives
Rapidly identifying the presence of deadly coronavirus has become one of the most urgent health needs in the U.S. The test can identify a patient’s symptoms within a few minutes, but only if a person is contagious.
The rapid tests are being tested in states like Minnesota and Kansas, but more testing is needed to see if the results are as useful as they could be.
“We need to have a rapid testing program that is available in the United States,” said Dr. David Cohen, a professor of emergency medicine at Boston University School of Medicine.
“The quicker we can get this test, the more effective it will be.”
The rapid test is designed to detect a virus that has already killed or sickened more than 10 people and is likely to spread to people who haven’t yet been diagnosed.
But its use in emergency rooms has been controversial.
Some health officials say that the rapid test can’t be used in every emergency room, and that it may not detect many cases of the virus.
Others say that it can identify people with milder symptoms, like coughs and sore throats, and can be used more effectively in cases of severe illness.
The Rapid Antibody Test Dr. Cohen and his colleagues at Boston’s Brigham and Women’s Hospital have developed a rapid test that they say can be easily administered at the scene of an emergency.
The results of the test are recorded and uploaded onto a central computer to help doctors quickly determine if someone is contagious and can potentially help them quickly find and isolate a patient who has the virus, the Boston Globe reported.
In addition to tracking people who have been exposed, the test can also help identify people who may be at increased risk of catching the virus after coming in contact with a sick person or another sick person.
Scientists are trying to develop the test for use in hospitals and other health care settings, like schools, that don’t have isolation rooms.
They hope to have the test ready for use by mid-2019, Cohen said.
If the test works well, the results can be a game changer in the fight against coronaviruses, and it may also help to identify people at risk of contracting the virus in the future.
“This is going to be an important tool in the hospital to identify patients who are at high risk of transmission from their close contact, so they can be tested quickly,” Dr. Michael Fung, a Boston University geriatrics professor who has led a team that developed the rapid-antibody test, told NBC News.
Fung said that while the test could not identify the exact virus responsible for the outbreak, it could identify who had the virus and how much they were contagious.
He said that if the test worked, the findings could be used to identify and isolate people at increased risks of transmission, and could help identify the person most at risk.
For now, the rapid tests have not been tested in a patient in a hospital setting, but the doctors plan to test in the near future.
“We are working to be able to do this as soon as we can,” Cohen said, adding that the tests are “highly effective” in the lab.
What to Know The test is called a Rapid Antigen Test (RAT) and it’s a small, portable device that takes about 30 minutes to administer.
It takes about 20 seconds to administer and can detect the virus If it detects that the patient has the coronaviral virus, it will then notify doctors in a few hours to tell them what to do with the patient.
It also has the ability to identify the virus at a level of detection that would require about 30 days of continuous testing.
However, since the test is still in its early days, and the tests haven’t been tested widely, there are still questions about how effective the test will be, experts say.
Experts say that while they believe that the test has the potential to be used effectively in emergency settings, the tests need to be tested widely in order to be widely effective.
Researchers are also concerned that the testing could make the problem of coronavirens more difficult for doctors to treat, which could hurt the health of the patients.
So far, there have been no reported cases of hospitalizations or deaths linked to the rapid antigen tests.
Read more: CDC to expand tests in emergency departments to more locations